Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 3CNS 1

Conditions

Glioblastoma 8Brain Neoplasms 8Gliosarcoma 5Central Nervous System Neoplasms 5Oligodendroglioma 3Glioma 3Astrocytoma 3Recurrence 2Neuroblastoma 2Neoplasms 2Meningioma 2Medulloblastoma 2Lymphoma 2Choroid Plexus Neoplasms 2Wilms Tumor 1Uterine Cervical Neoplasms 1Sarcoma 1Rectal Neoplasms 1Pinealoma 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Extranodal NK-T-Cell 1Liver Neoplasms 1Head and Neck Neoplasms 1

Interventions

vandetanib 2Bevacizumab 2Anthropogenic Effects 2enzastaurin 1carotuximab 1Temozolomide 1Tamoxifen 1Steroids 1Irinotecan 1Carboplatin 1Bortezomib 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease Progression × Bortezomib × CNS × Clear all
NCT00108069 2015-11-05

Tamoxifen and Bortezomib to Treat Recurrent Brain Tumors

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
43 enrolled 11 charts
CNS

Brain Neoplasms, Glioma, Neoplasms, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡